Mastery EAQ Ch. 30

A  Somatropin

B  Corticotropin

C  Octreotide

D  Desmopressin

A  Desmopressin

B  Somatropin

C  Octreotide

D  Vasopressin

A  “Skip the missed dose and resume your usual dosage schedule.”

B  “You should consult your primary health care provider immediately.”

C  “If it is almost time for your next dose, take a double dose of the drug at that time.”

D  “You can take the dose immediately when you remember it.”

A  Desmopressin

B  Vasopressin

C  Somatropin

D  Cosyntropin

A  Vertigo

B  Bleeding gums

C  Abdominal stress

D  Drowsiness

A  “Heat the medicine before administration.”

B  “Do not administer the drug to the patient.”

C  “Keep the bottle in warm water before administration.”

D  “Shake the medication before administration.”

A  Evaluate the patient for limping.

B  Monitor fluid status.

C  Monitor blood glucose levels closely.

D  Encourage vigorous exercise.

A  Monitoring the patient in an intensive care unit

B  Co-administering carbamazepine

C  Administering the vasopressin intravenously

D  Obtaining liver and renal function tests

A  Bleeding gums

B  Excessive thirst

C  Limping

D  Abdominal cramps

A  Headache, Low urine output, Low blood pressure, Nausea

B  Nausea, Blood glucose elevation, Headache, Low urine output

C  Nausea, Blood glucose elevation, Headache, Low blood pressure

D  Low blood pressure, Blood glucose elevation, Headache, Low urine output

A  Desmopressin intravenously

B  Octreotide subcutaneous

C  Somatropin intramuscular

D  Vasopressin nasal spray

A  Blood glucose

B  Electrocardiogram (ECG)

C  Liver enzymes

D  Renal panel

A  Previous somatropin injection site tender to touch.

B  Radiology report identifies no fracture with closed growth plates.

C  Growth percentile has increased from the previous annual physical.

D  Reports episodic muscle pain during the past year.

A  Review current laboratory values for blood glucose

B  Review the frequency with the health care provider

C  Calculate the dosage with the pharmacist or another nurse

D  Obtain baseline weight and height measurements

A  Inquire about abdominal discomfort

B  Assess the patient for headaches

C  Notice increase in body temperature

D  Monitor for signs of infiltration

A  Edema of the extremities, Elevated blood pressure

B  Weight gain, Edema of the extremities

C  Elevated blood pressure, Weight gain

D  Increased urination, Thirst

A  Watch the IV site closely for infiltration.

B  Measure the patient’s urine output regularly.

C  Assess for signs of dehydration.

D  Make a note of the fluid intake.

A  Small-bowel fistula and having an acute asthma attack

B  Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

C  Acromegaly and a serum creatinine level of 5.0 mg/dL

D  Esophageal varices and a history of type 2 diabetes

A  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Monitor the level of drug left in the pump.
6. Replace the cap on the bottle.

B  1. Clear the nasal passages.
2. Give half a spray in each nostril.
3. Place the spray nozzle in the nostril.
4. Prime the pump by pressing down four times.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

C  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

D  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Replace the cap on the bottle.
5. Give half a spray in each nostril.
6. Monitor the level of drug left in the pump.

A  Patient D: VIP; severe diarrhea and flushing; renal impairment

B  Patient C: VIP; life-threatening hypotension; diarrhea and flushing

C  Patient A: esophageal varices; type 1 diabetes

D  Patient B: carcinoid tumor; taking ciprofloxacin

A  Diarrhea, Flushing

B  Joint pain, Fatigue

C  Fatigue, Headache

D  Headache, Joint pain

A  The medication is not effective for this condition.

B  The patient needs to adjust fluid intake.

C  A higher dose of medication is required for treatment.

D  The patient is stable and needs reassurance.

A  Priming the pump each week

B  Storing the pump at room temperature

C  Inhaling the medication into the airway

D  Administering half the dose in each nostril

A  “Is there any change in the color of your sputum?”
“Do you have excessive bleeding due to minor injuries?”

B  “Do you feel very thirsty lately?”
“How many times do you urinate in a day?”

C  “Is there any change in the color of your urine?”
“Is there any change in the color of your sputum?”

D  “Do you have excessive bleeding due to minor injuries?”
“Is there any change in the color of your urine?”

A  Height, Weight, Motor skills

B  Skin turgor, Height, Visual acuity

C  Motor skills, Visual acuity, Skin turgor

D  Weight, Skin turgor, Visual acuity

A  Replacing the cap on the pump after the procedure

B  Pressing down on the pump two times to prime it

C  Pressing the pump once to spray a 10-mcg dose

D  Priming the nasal pump once a week

A  Hypothyroidism

B  Hypercalciuria

C  Hyperglycemia

D  Hypertension

A  “Apply the drug preparation topically to the nasal membranes.”

B  “Dilute the drug preparation before administration.”

C  “Shake the drug preparation thoroughly before use.”

D  “Inhale the drug preparation by spraying into the nostrils.”

A  Loss of consciousness

B  Abundant, diluted urine

C  Oozing blood

D  Watery diarrhea

A  Acute bronchitis with laryngitis

B  Human immunodeficiency virus (HIV) infection

C  Cachexia and closed growth plates

D  Bilateral metastatic breast cancer

A  A 10-year-old of short stature who has severe asthma

B  An 8-year-old with a pituitary tumor

C  A 17-year-old who is 5 feet tall

D  A 7-year-old diagnosed with growth hormone deficiency

A  Vasopressin and demeclocycline

B  Desmopressin and carbamazepine

C  Somatropin and glucocorticoids

D  Vasopressin and carbamazepine

A  Seizures

B  Edema

C  Hypoglycemia

D  Heartburn

A  Hypokalemia

B  Hyperglycemia

C  Hyponatremia

D  Orthostatic hypotension

A  Glucocorticoids

B  Cyclosporine

C  Fludrocortisone

D  Ciprofloxacin

A  Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

B  Diabetes insipidus, Seizure, Type I von Willebrand

C  Seizure, Asthma, Cardiovascular disease

D  Asthma, Diabetes insipidus, Type I von Willebrand

A  Decreases growth

B  Reduces weight loss

C  Decreases fluid retention

D  Reduces fat levels

A  Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

B  Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

C  Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

D  Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

A  Thioridazine

B  Norepinephrine

C  Acetaminophen

D  Carbamazepine

A  Renal function studies, Liver enzyme levels, Blood pressure

B  Liver enzyme levels, Renal function studies, Weight

C  Weight, Blood pressure, Blood glucose levels

D  Liver enzyme levels, Blood glucose levels, Renal function studies

A  Constipation, Malaise, Hypercalciuria

B  Malaise, Dyspnea,

C  Arthralgia, Hypercalciuria, Constipation

D  Dyspnea, Constipation, Hypercalciuria

A  Edema

B  Inflammation

C  Hypotension

D  Scar formation

A  Causes prolongation of QT interval

B  Reduces the effects of desmopressin

C  Produces an additive effect

D  Enhances the effects of desmopressin

A  Somatropin

B  Octreotide

C  Vasopressin

D  Desmopressin

A  Cosyntropin

B  Octreotide

C  Desmopressin

D  Somatropin

A  Polydipsia

B  Polyuria

C  Headache

D  Dehydration

A  Cosyntropin

B  Oxytocin

C  Thyroid hormone

D  Octreotide

A  Ciprofloxacin

B  Carbamazepine

C  Demeclocycline

D  Cyclosporine

A  Complete blood count result

B  Creatinine clearance test

C  Uric acid level

D  Blood glucose level

A  Somatropin

B  Desmopressin

C  Vasopressin

D  Luteinizing hormone

A  Polydipsia

B  Hypopituitary dwarfism

C  Acromegaly

D  Polyuria

A  Octreotide

B  Vasopressin

C  Oxytocin

D  Cosyntropin

A  Somatolactin

B  Somatostatin

C  Choriomammotropin

D  Somatropin

A  Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

B  Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

C  Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

D  Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

A  Relief of pain

B  Decreased adrenocorticotropic hormone levels

C  Increased serum albumin levels

D  Increased urine specific gravity